Brief: Tenax Announces New Publication Highlighting Novel Levosimendan Mechanism Of Action In Pulmonary Hypertension Patients With Heart Failure And Preserved Ejection Fraction (Ph-Hfpef)

Tenax Therapeutics

12/08/2021 13:10

Aug 12 (Reuters) - Tenax Therapeutics Inc  TENX.O :
    * TENAX ANNOUNCES NEW PUBLICATION HIGHLIGHTING NOVEL
LEVOSIMENDAN
MECHANISM OF ACTION IN PULMONARY HYPERTENSION PATIENTS WITH
HEART FAILURE AND PRESERVED EJECTION FRACTION (PH-HFPEF)

Source text for Eikon:  ID:nBwn4ld8a 
Further company coverage:  TENX.O 

 ((Reuters.Briefs@thomsonreuters.com;))